ReNeuron
Human somatic stem cells.
One technology, utilizing the c-myc gene, successfully and cost-effectively grow selected human stem cells into banks of cell lines and also enables the production of stable cells which retain their essential characteristics.
ReNeuron's c-mycERTAM technology allows for the efficient creation of hundreds of stem cell lines from an individual tissue sample. ReNeuron has developed a screening platform that enables optimal stem cell lines for each indication to be progressed into pre-clinical development. The cells are tested for cell characteristics, growth and bankability, as well as their capacity to engraft, with minimal immune rejection, in the relevant disease model. ReNeuron has also developed a prototype stem cell line capable of producing, in high concentrations, dopamine-producing cells of the type deficient in patients with Parkinson's disease.
Also leveraging stem cell technologies into non-therapeutic areas such as drug discovery – "ReNcell"
http://www.reneuron.com/
